Company intelligence / Profile preview

seqWell

Beverly, Massachusetts, United Statesseqwell.com ↗

Ownership: Private
Employees: ~40
Development stage: Commercial

Overview

seqWell develops and commercializes innovative NGS library preparation platforms such as plexWell™, enabling scalable multiplexing of hundreds to thousands of samples with simplified workflows. Their technologies are used in a wide range of genomics applications including single-cell analysis, targeted sequencing, synthetic biology, and whole genome sequencing for human, plant, animal, and microbial samples. The company’s products have been adopted by academic core facilities and research labs to streamline high-throughput sequencing projects.

No clinical results apply as the company does not develop therapeutics.

Industry: Chemicals & Materials

Beyond the preview

Go deeper on seqWell.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on seqWell.

Explore the full profile